143 related articles for article (PubMed ID: 6235073)
1. Defective erythrocyte C3b receptor function associated with low serum complement (C3, C4) concentrations in insulin-dependent diabetes mellitus.
Ruuska P; Ilonen J; Mustonen A; Tiilikainen A
Clin Exp Immunol; 1984 Jul; 57(1):12-6. PubMed ID: 6235073
[TBL] [Abstract][Full Text] [Related]
2. Secretor state and complement levels (C3 and C4) in insulin dependent diabetes mellitus.
Blackwell CC; Weir DM; Patrick AW; Collier A; Clarke BF
Diabetes Res; 1988 Nov; 9(3):117-9. PubMed ID: 3243044
[TBL] [Abstract][Full Text] [Related]
3. [Serum immunoglobulins and various components of complement in patients with insulin-dependent diabetes mellitus].
Pietruska Z; Kinalska I; Jabłońska E; Czaczkowska T
Przegl Lek; 1989; 46(3):338-41. PubMed ID: 2772239
[TBL] [Abstract][Full Text] [Related]
4. Chronic myelocytic leukaemia: HLA association and decreased erythrocyte C3b receptor expression.
Ruuska P; Silvennoinen-Kassinen S; Timonen T; Tiilikainen A
Clin Exp Immunol; 1985 Feb; 59(2):300-4. PubMed ID: 3156701
[TBL] [Abstract][Full Text] [Related]
5. Studies on immune adherence (C3b) receptor activity of human erythrocytes: relationship between receptor activity and presence of immune complexes in serum.
Inada Y; Kamiyama M; Kanemitsu T; Hyman CL; Clark WS
Clin Exp Immunol; 1982 Oct; 50(1):189-97. PubMed ID: 6216998
[TBL] [Abstract][Full Text] [Related]
6. [Decrease in the serum level of the C3 complement component in noninsulin dependent diabetes of recent onset].
Vialettes B; Lassmann V; Vague P
Diabete Metab; 1983 Mar; 9(1):66-8. PubMed ID: 6602072
[TBL] [Abstract][Full Text] [Related]
7. [The silent allele of complement C4 BQ0 is associated with increase risk if insulin-dependent diabetes (IDDM)].
Marcelli-Barge A; Schmid M; Poirier JC; Deschamps I; Hors J
Journ Annu Diabetol Hotel Dieu; 1985; ():149-56. PubMed ID: 2577959
[No Abstract] [Full Text] [Related]
8. [HLA typing and insulin antibody production in insulin-dependent diabetics].
Bruni B; Barolo P; Gadaleta G; Gamba Ansaldi S; Grassi G; Zerbinati A; Molinatti M; Salvetti E
Ann Osp Maria Vittoria Torino; 1984; 27(7-12):185-213. PubMed ID: 6443704
[TBL] [Abstract][Full Text] [Related]
9. [Erythrocyte CR1 receptor reactivity in patients with systemic lupus erythematosus].
Said PB; Sarano J; Manni JA; Casellas AM
Medicina (B Aires); 1990; 50(1):21-4. PubMed ID: 2149869
[TBL] [Abstract][Full Text] [Related]
10. The HLA association of insulin-dependent (type I) diabetes mellitus.
Bertrams J
Behring Inst Mitt; 1984 Jul; (75):89-99. PubMed ID: 6333238
[TBL] [Abstract][Full Text] [Related]
11. Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus.
Daha MR; Hazevoet HM; Hermans J; van Es LA; Cats A
Clin Exp Immunol; 1983 Oct; 54(1):248-52. PubMed ID: 6604610
[TBL] [Abstract][Full Text] [Related]
12. Which complement assays and typings are necessary for the diagnosis of complement deficiency in patients with lupus erythematosus? A study of 25 patients.
Boeckler P; Meyer A; Uring-Lambert B; Goetz J; Cribier B; Hauptmann G; Lipsker D
Clin Immunol; 2006 Nov; 121(2):198-202. PubMed ID: 16987709
[TBL] [Abstract][Full Text] [Related]
13. Quantification of the complement receptor function on polymorphonuclear leukocytes: its significance in patients with systemic lupus erythematosus.
Yoshida K; Yukiyama Y; Miyamoto T
J Rheumatol; 1987 Jun; 14(3):490-6. PubMed ID: 3498035
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism of the complement components in human pathology.
Brai M; Accardo P; Bellavia D
Ann Ital Med Int; 1994; 9(3):167-72. PubMed ID: 7946894
[TBL] [Abstract][Full Text] [Related]
15. [The HLA system and insulin-dependent diabetes mellitus. A review and personal studies].
Citro M; Gadaleta G; Gamba Ansaldi S; Molinatti M; Salvetti E; Bruni B
Ann Osp Maria Vittoria Torino; 1983; 26(1-6):108-42. PubMed ID: 6388459
[TBL] [Abstract][Full Text] [Related]
16. Is immunity in diabetic patients influencing the susceptibility to infections? Immunoglobulins, complement and phagocytic function in children and adolescents with type 1 diabetes mellitus.
Liberatore RR; Barbosa SF; Alkimin Md; Bellinati-Pires R; Florido MP; Isaac L; Kirschfink M; Grumach AS
Pediatr Diabetes; 2005 Dec; 6(4):206-12. PubMed ID: 16390389
[TBL] [Abstract][Full Text] [Related]
17. [Complement fractions and their variations with the duration of insulin-dependent diabetes in children].
de Menibus CH; Mallet E; Sauger F
LARC Med; 1981 Dec; 1(3):59. PubMed ID: 7349689
[No Abstract] [Full Text] [Related]
18. Correlative expression of C3b receptors in the glomerulus and on erythrocytes.
Minota S; Terai C; Nojima Y; Takano K; Yamada A; Miyakawa Y; Takaku F
Clin Immunol Immunopathol; 1986 Jan; 38(1):85-92. PubMed ID: 2934197
[TBL] [Abstract][Full Text] [Related]
19. Circulating Fc-receptor blocking factors in IgA nephropathies.
Roccatello D; Coppo R; Piccoli G; Cordonnier D; Martina G; Rollino C; Picciotto G; Sena LM; Amoroso A
Clin Nephrol; 1985 Apr; 23(4):159-68. PubMed ID: 3874036
[TBL] [Abstract][Full Text] [Related]
20. Complement-dependent antibody mediated cytotoxicity (C'AMC) in patients with newly diagnosed insulin-dependent diabetes mellitus.
Hehmke B; Michaelis D; Hildmann W; Richter KV; Kohnert KD
Exp Clin Endocrinol; 1987 Aug; 89(3):375-82. PubMed ID: 3666052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
